THE Therapeutic Goods Administration has released new support materials specifically for pharmacists to use when engaging with customers about the forthcoming rescheduling of codeine-containing products.
The content includes a special pharmacist fact sheet detailing the reasons for the change, support for clinical decisions about alternative pain treatments and a warning about stockpiling the products.
See www.tga.gov.au for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jul 17
